UnitedHealth Earnings Beat Wall Street, But Medical Costs Rise
UnitedHealth Group (UNH) reported Q4 2025 earnings that beat Wall Street expectations, with revenue of $100.8 billion and adjusted EPS of $6.85. The company raised its full-year guidance, but the medical cost ratio increased to 84.2%, indicating persistent cost pressures.
Key Numbers
UnitedHealth Group (UNH) reported Q4 2025 results that surpassed analyst estimates, with revenue reaching $100.8 billion, up 8% year-over-year. Adjusted earnings per share came in at $6.85, above the consensus estimate of $6.65. The stock rose 2.3% in pre-market trading.
Key Financial Results
| Metric | Q4 2025 | Q4 2024 | Change |
|---|---|---|---|
| Revenue | $100.8B | $93.4B | +8% |
| Net Income | $5.2B | $4.8B | +8.3% |
| Adjusted EPS | $6.85 | $6.20 | +10.5% |
| Medical Cost Ratio | 84.2% | 83.5% | +0.7 pp |
Highlights from the Release
The company attributed revenue growth to increased enrollment in Medicare Advantage plans and expansion of home health services. However, the medical cost ratio (MCR) rose to 84.2%, reflecting higher utilization of medical services among members.
Forward Guidance
UnitedHealth raised its adjusted EPS guidance for fiscal 2026 to a range of $28.50-$29.00, up from the prior estimate of $27.50-$28.00. The company also expects full-year revenue between $410 billion and $415 billion.
Impact on the Stock
UNH shares rose 2.3% in pre-market trading, but analysts cautioned that the rising MCR could limit future gains. The stock is still down about 5% year-to-date.
What This Means for Investors
The results demonstrate UnitedHealth's ability to grow despite inflationary pressures in healthcare. However, the rising medical cost ratio warrants monitoring, especially if it continues to increase in coming quarters.
Frequently Asked Questions
Found this useful? Share it